CA Stock MarketDetailed Quotes
LBL Lattice Biologics Ltd
- 0.000
- 0.0000.00%
15min DelayMarket Closed Nov 8 09:30 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.04052wk High0.00%Turnover Ratio128.22MShares0.04052wk Low-0.013EPS TTM0Float Cap44.800Historical High0.00P/E (Static)49.01MShs Float0.005Historical Low-0.013EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
Lattice Biologics Ltd Key Stats
Quarterly+Annual
YOY
| (Q3)Jun 30, 2021 | (Q2)Mar 31, 2021 | (Q1)Dec 31, 2020 | (FY)Sep 30, 2020 | (Q4)Sep 30, 2020 | (Q3)Jun 30, 2020 | (Q2)Mar 31, 2020 | (Q1)Dec 31, 2019 | (FY)Sep 30, 2019 | (Q4)Sep 30, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | -38.07%287.65K | -32.19%474.57K | 12.60%2.46M | 52.37%795.78K | 12.56%504.22K | -38.16%464.45K | 49.77%699.9K | 89.49%2.19M | 87.55%522.26K |
| Operating revenue | --0 | -38.07%287.65K | -32.19%474.57K | 12.60%2.46M | 52.37%795.78K | 12.56%504.22K | -38.16%464.45K | 49.77%699.9K | 89.49%2.19M | 87.55%522.26K |
| Cost of revenue | 0 | 40.09%283.86K | -17.97%246.09K | 15.88%1.44M | -8.93%583.51K | 24.39%357.59K | 17.27%202.63K | 107.12%300.01K | 102.95%1.25M | 136.09%640.75K |
| Gross profit | 0 | -98.55%3.79K | -42.86%228.49K | 8.26%1.02M | 279.15%212.27K | -8.64%146.62K | -54.73%261.82K | 24.01%399.89K | 74.21%942.76K | -1,778.03%-118.49K |
| Operating expense | -93.09%25.85K | 17.77%393.21K | -2.12%345.33K | -15.92%1.28M | -48.69%224.4K | -0.03%373.88K | -14.17%333.89K | 7.56%352.81K | -24.53%1.53M | -36.04%437.32K |
| Selling and administrative expenses | -92.33%25.85K | 21.61%333.86K | 10.85%323.52K | -17.22%1.14M | -41.62%232.95K | 0.10%336.84K | -21.94%274.54K | 2.31%291.84K | -26.75%1.37M | -38.12%399.02K |
| -Selling and marketing expense | 185.91%25.85K | 4.15%2.46K | -31.67%9.88K | -37.47%55.45K | -2.37%29.6K | -63.75%9.04K | -91.77%2.36K | 206.12%14.45K | -40.66%88.67K | -43.54%30.32K |
| -General and administrative expense | ---- | 21.76%331.4K | 13.07%313.65K | -15.82%1.08M | -44.85%203.35K | 5.20%327.8K | -15.73%272.18K | -1.12%277.39K | -25.55%1.28M | -37.62%368.71K |
| Research and development costs | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 196.38%6.48K | -38.56%1.01K |
| Depreciation amortization depletion | --0 | 0.00%59.35K | -64.22%21.81K | 47.50%220.3K | 68.83%62.95K | -1.15%37.04K | 59.12%59.35K | 63.45%60.96K | 0.11%149.35K | -0.04%37.28K |
| -Depreciation and amortization | --0 | 0.00%59.35K | -64.22%21.81K | 47.50%220.3K | 68.83%62.95K | -1.15%37.04K | 59.12%59.35K | 63.45%60.96K | 0.11%149.35K | -0.04%37.28K |
| Other operating expenses | ---- | ---- | ---- | ---71.5K | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | 88.63%-25.85K | -440.34%-389.42K | -348.17%-116.84K | 54.85%-264.37K | 97.82%-12.13K | -6.44%-227.26K | -138.07%-72.07K | 947.56%47.08K | 60.54%-585.56K | 17.86%-555.8K |
| Net non-operating interest income (expenses) | 0 | 0 | 5.74%-114.93K | -91.17%-1.04M | -112.61%-456.68K | 0.54%-103.54K | -222.90%-358.34K | -6.59%-121.93K | -16.54%-544.27K | -10.33%-214.8K |
| Non-operating interest expense | --0 | --0 | -5.74%114.93K | 91.17%1.04M | 112.61%456.68K | -0.54%103.54K | 222.90%358.34K | 6.59%121.93K | 16.54%544.27K | 10.33%214.8K |
| Other net income (expenses) | -853.43%-37.36K | -250.76%-177.77K | 123.57%229.53K | -58.12%11.05K | -2,489.83%-423.31K | -4.78%4.96K | -83.62%117.92K | -81.84%102.66K | ||
| Gain on sale of security | ---- | ---- | -986.24%-37.36K | -224.76%-52.23K | 2.98%30.49K | 1,086.05%304.28K | -1,207.60%-391.22K | -74.48%4.22K | -79.69%41.87K | -67.04%29.61K |
| Other non-operating income (expenses) | ---- | ---- | ---- | -265.07%-125.54K | 172.46%199.03K | -39,832.66%-293.23K | -336.39%-32.09K | 106.57%743 | 70.62%76.05K | 1,049.87%73.05K |
| Income before tax | 91.92%-25.85K | 54.39%-389.42K | -285.06%-269.13K | -46.52%-1.48M | 64.18%-239.29K | -9.80%-319.74K | -1,477.52%-853.72K | 39.09%-69.89K | 17.80%-1.01M | -118.33%-667.94K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 91.92%-25.85K | 54.39%-389.42K | -285.06%-269.13K | -46.52%-1.48M | 64.18%-239.29K | -9.80%-319.74K | -1,477.52%-853.72K | 39.09%-69.89K | 17.80%-1.01M | -118.33%-667.94K |
| Net income continuous operations | 91.92%-25.85K | 54.39%-389.42K | -285.06%-269.13K | -46.52%-1.48M | 64.18%-239.29K | -9.80%-319.74K | -1,477.52%-853.72K | 39.09%-69.89K | 17.80%-1.01M | -118.33%-667.94K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 91.92%-25.85K | 54.39%-389.42K | -285.06%-269.13K | -46.52%-1.48M | 64.18%-239.29K | -9.80%-319.74K | -1,477.52%-853.72K | 39.09%-69.89K | 17.80%-1.01M | -118.13%-667.94K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 91.92%-25.85K | 54.39%-389.42K | -285.06%-269.13K | -46.52%-1.48M | 64.18%-239.29K | -9.80%-319.74K | -1,477.52%-853.72K | 39.09%-69.89K | 17.80%-1.01M | -118.13%-667.94K |
| Diluted earnings per share | 93.71%-0.0002 | 69.63%-0.003 | -180.61%-0.0021 | 0.00%-0.01 | 0 | -3.08%-0.0032 | -1,608.30%-0.01 | 39.09%-0.0007 | 0.00%-0.01 | -0.0063 |
| Basic earnings per share | 93.71%-0.0002 | 69.63%-0.003 | -180.61%-0.0021 | 0.00%-0.01 | 0 | -3.08%-0.0032 | -1,608.30%-0.01 | 39.09%-0.0007 | 0.00%-0.01 | -0.0071 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data